Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](Global Blood Therapeutics)"
Count: 28
Selected: 0
NCT IDTitle
NCT05036512A Study to Evaluate GBT021601 in Single and Multiple Doses in Healthy Participants
NCT04983264A Study to Evaluate GBT021601-012 Single Dose and Multiple Dose in Participants With Sickle Cell Disease (SCD)
NCT04935879A Study to Assess the Safety and Efficacy of Inclacumab in Participants With Sickle Cell Disease Experiencing Vaso-occlusive Crises
NCT04930445Oxbryta® Product Registry An Observational Study Designed to Evaluate the Effect of Oxbryta in Individuals With SCD
NCT04930328Retrospective Real World Oxbryta® Data Collection and Analysis Study
NCT04927247A Study of a Single Dose of Inclacumab to Reduce Re-admission in Participants With Sickle Cell Disease and Recurrent Vaso-occlusive Crises
NCT04724421Expanded Access Protocol for Pediatric Patients With Sickle Cell Disease Who Have No Alternative Treatment Options
NCT04400487Actigraphy Improvement With Voxelotor (ActIVe) Study
NCT04247594Dose Escalation Study to Evaluate the Safety, Tolerability, PK and PD of Voxelotor in Patients With SCD
NCT04218084Study to Evaluate the Effect of GBT440 on TCD in Pediatrics With Sickle Cell Disease
NCT04188509Pediatric Open-Label Extension of Voxelotor
NCT03943615Expanded Access to Voxelotor for Patients With Sickle Cell Disease Who Have No Alternative Treatment Options
NCT03573882Study to Assess the Effect of Long-term Treatment With Voxelotor in Participants Who Have Completed Treatment in Study GBT440-031
NCT03161015Single-Dose PK Study of GBT440 in Subjects With Renal Impairment
NCT03114540Single-Dose PK and Safety Study of GBT440 in Subjects With Hepatic Impairment
NCT03051711Study to Evaluate Effects of Investigational Drug on Oxygenation in Healthy Volunteers Under Hypoxic Conditions
NCT03041909An Extension Study to Further Evaluate the Safety, Tolerability of GBT440 in Patients With Sickle Cell Disease Who Participated in the Study GBT440-001
NCT03036813Study to Evaluate the Effect of Voxelotor Administered Orally to Patients With Sickle Cell Disease (GBT_HOPE)
NCT02989168Study to Evaluate the Effect of GBT440 Administered to Subjects With IPF on Supplemental Oxygen at Rest
NCT02850406Study to Evaluate the Effect of GBT440 in Pediatrics With Sickle Cell Disease
NCT02846324Study to Evaluate the Safety and Tolerability of GBT440 Administered to Subjects With IPF
NCT02567695A Single-Dose Relative Bioavailability Study Of GBT440 300 mg Capsules in Healthy Subjects
NCT02567682Drug Interaction Study of GBT440 With Caffeine, S-warfarin, Omeprazole, and Midazolam in Healthy Subjects
NCT02497924A Study of the Absorption, Metabolism, and Excretion of GBT440 in Healthy Male Subjects
NCT02285088A Study of the Safety, Blood Levels and Biological Effects of GBT440 in Healthy Subjects and Subjects With Sickle Cell Disease
NCT05018728The Effect of Voxelotor on Cerebral Hemodynamic Response in Children With Sickle Cell Anemia
NCT04335721A Voxelotor for Sickle Cell Anemia Patients at Highest Risk for Progression of Chronic Kidney Disease
NCT04581356Voxelotor Sickle Cell Exercise Study